Role of molecularly imprinted hydrogels in drug delivery - A current perspective.

Molecular imprinting in hydrogels crafts memory for template molecules in a flexible macromolecular structure. Molecular imprinting can control the pattern of the drug release via different mechanistic pathways which may involve swelling, which releases the drug via diffusion or receptive-swollen networks. Responsive hydrogels or smart hydrogels can be tailored to undergo a change in the network structure in response to a stimulus by inserting specific chemical or biological entities along their backbone polymer chains. The stimuli which can be either physical, chemical or biochemical in nature, may impact at various energy levels thereby initiating the molecular interactions at critical onset points. Conventional hydrogels lack in responding to an external stimuli in a swift manner, hence the molecular imprinting technology can significantly advance the therapeutic efficiency of the drugs with anticipated controlled release and targeting efficiency. Molecular imprinting in hydrogels is thus anticipated as a step towards establishment of drug delivery systems by providing improved delivery profiles or longer release times and deliver the drugs in a feedback regulated way. The review article focuses on the current scenario of molecularly imprinted hydrogels with emphasis on the imprinting strategies within hydrogels and challenges encountered, latent translational applications, and future perspectives.

Assay and Dermatokinetics of Tetrahydrocurcumin Lipidic Nanostructures Using Reverse Phase-high Performance Liquid Chromatography.

BACKGROUND: Envisaging the poor solubility (56 ngml1) and permeability of tetrahydrocurcumin (THCC), it was formulated into lipidic nanostructures to enhance its bioavailability upon topical application to promote the healing process for skin inflammatory disorders. Lack of literature on a suitable method for determining THCC per se and nanoformulations prompted us to develop an RP-HPLC method to detect the drug in its nanostructures and in pig ear skin post dermatokinetics. OBJECTIVE: The present investigation aimed to develop a simple, precise and RP-HPLC method for the quantitative estimation of THCC in prepared lipidic nanostructures, its ointment, and in skin homogenate obtained post dermatokinetic study. METHODS: THCC encapsulated nanostructures and ointment were formulated using a modified emulsification method and embedded into an ointment base to enhance its spreadability and improve patient compliance. A fast and sensitive reverse-phase high-performance liquid chromatography method was developed using a Hypersil BDS reverse phase C18 column (4.6 mm × 250 mm, 5 µm) with mobile phase comprising tetrahydrofuran (THF) and 1 mgmL-1 citric acid (4:6), at a flow rate of 1.0 mLmin-1 with a run time of 20 min. RESULTS: THCC nanostructures were successfully prepared using the spontaneous microemulsification method. THCC was detected at 282 nm and revealed two peaks which were attributed to the keto-enol tautomerism in the molecule with retention times of 6.23 min and 11.06 min, respectively. The assay of THCC in nanostructures and ointment was found to be 98.30 % and 99.98 %, with an entrapment efficiency 77.00±2.74 %. The dermatokinetic studies revealed sufficient release of THCC from its ointment up to 24 hr with a concentration of 1382 µgcm-2, for causing a therapeutic effect. CONCLUSION: The method was found to be reproducible and robust, as shown by the low coefficient of variation and a constant analyte/IS ratio. It was successfully employed for the estimation of THCC assay in nanostructures and its ointment and dermatokinetic analysis in the skin.

A Schiff base modified graphene oxide film for anodic stripping voltammetric determination of arsenite.

A protocol is described for chemical modification of graphene oxide with a Schiff base derived from diethylenetriamine and 2-hydroxy-4-methoxybenzophenone. The base was grafted onto an indium tin oxide (ITO) film and applied to electroanalytical determination of arsenite. Successful grafting was confirmed by Fourier transform-infrared spectroscopy, spectrophotometry, field emission scanning electron microscopy and cyclic voltammetry. Secondly, the coated ITO film served as a working electrode for the stripping voltammetric determination of arsenite. The analytical signal is generated by selective oxidation of metal species via multi-donor sites present in the derivatized Schiff base. The electroanalytical protocol was optimized by investigating the effects of deposition time, working potential, frequency and amplitude of square wave anodic stripping voltammetry. The method has attractive features including (a) the usage of a non-metallic, non-toxic and cost-effective material; (b) improved sensitivity (with limit of detection as low as 156 pM) due to better adsorption of arsenite in the Schiff base pockets on the ITO, and (c) the application to the determination of arsenite in real samples. Graphical abstract Schematic representation of the fabrication of a Schiff base-functionalized graphene oxide on an indium tin oxide (SB@SiO2@GO@ITO) electrode for selective electrochemical sensing of arsenite due to adsorption on multi-donor sites.

Imprinted silica nanoparticles coated with N-propylsilylmorpholine-4-carboxamide for the determination of m-cresol in synthetic and real samples.

m-Cresol-imprinted silica nanoparticles coated with N-propylsilylmorpholine-4-carboxamide have been developed that contain specific pockets for the selective uptake of m-cresol. Silica nanoparticles were synthesized by a sol-gel process followed by functionalization of their surface with N-propylsilylmorpholine-4-carboxamide. The formation of m-cresol-imprinted silica nanoparticles was confirmed by UV-Vis spectrophotometry, infrared spectroscopy, thermogravimetric analysis, scanning electron microscopy and transmission electron microscopy. Electron microscopic studies revealed the formation of monodispersed imprinted silica nanoparticles with spherical shape and an average size of 83 nm. The developed nanoparticles were filled in a syringe and used for the extraction of m-cresol from aqueous samples followed by quantification using high-performance liquid chromatography with diode array detection. Various adsorption experiments showed that developed m-cresol-imprinted silica nanoparticles exhibited a high adsorption capacity and selectivity and offered a fast kinetics for rebinding m-cresol. The chromatographic quantification was achieved using mobile phase consisting of acetonitrile/water (70:30 v/v) at an isocratic flow rate of 1.0 mL/min using a reversed-phase C18 column and detection at λmax = 275 nm. The limits of detection and quantification were 1.86 and 22.32 ng/mL, respectively, for the developed method. The percent recoveries ranged from 96.66-103.33% in the spiked samples. This combination of this nanotechnique with molecular imprinting was proved as a reliable, sensitive and selective method for determining the target from synthetic and real samples.

Development of molecularly imprinted microspheres for the fast uptake of 4-cumylphenol from water and soil samples.

Molecularly imprinted microspheres containing binding sites for the extraction of 4-cumylphenol have been prepared for the first time. The imprinted microspheres were synthesized by a precipitation method using 4-cumylphenol as a template molecule, methacrylic acid as a functional monomer and divinylbenzene-80 as a cross-linker for polymer network formation. The formation and the morphology of molecularly imprinted microspheres were well characterized using infrared spectroscopy, thermogravimetric studies, and scanning electron microscopy. The Brunauer-Emmett-Teller analysis revealed the high surface area of the sorbent indicating formation of molecularly imprinted microspheres. The developed microspheres were employed as a sorbent for the solid-phase extraction of 4-cumylphenol and showed fast uptake kinetics. The sorption parameters were optimized to achieve efficient sorption of the template molecule, like pH, quantity of molecularly imprinted microspheres, time required for equilibrium set-up, sorption kinetics, and adsorption isotherm. A standard method was developed to analyze the sorbed sample quantitatively at 279 nm using high-performance liquid chromatography with diode array detection. It was validated by determining target analyte from synthetic samples, bottled water, spiked tap water, and soil samples. The prepared material is a selective and robust sorbent with good reusability.

Metal assisted approach to develop molecularly imprinted mesoporous material exhibiting pockets for the fast uptake of diethyl phthalate as copper complex.

A new molecularly imprinted mesoporous material (MIM) containing specific pockets for the extraction of diethyl phthalate (DEP) as copper complex has been prepared for the first time. The mesoporous material was developed by utilizing copper-phthalate complex (Cu-DEP) as the template molecule, 3-aminopropyltriethoxysilane (APS) as a functional monomer and tetraethoxyorthosilicate (TEOS) as the silica source for polymer network formation. The mesoporous material showed fast uptake kinetics, and equilibrium was obtained within 30 min due to the introduction of copper, which provides an additional site for interaction with the functional monomer. Synthesized polymer was well characterized using UV-Vis spectrophotometry, IR spectroscopy, TGA studies, and TEM. To achieve efficient extraction of the template molecule, various factors including sorption kinetics, quantity of MIM, time required for equilibrium set-up, sorption isotherm and reuse of MIM were optimized. The extracted DEP samples were analyzed quantitatively at 310 nm using an HPLC-DA system. The prepared material is robust and can be reused. In addition, it was found to be selective for DEP as compared to other phthalates.

Medication reconciliation in hospice: a pilot study.

BACKGROUND: The Joint Commission required implementation of medication reconciliation processes by January 2006. Medication reconciliation is the practice of acquiring an accurate medication history at each transitional point of care. Potential for errors increases with inaccurate medication histories. This study determined the extent of medication reconciliation errors in hospice. METHODS: Patients were enrolled from 2 hospices in Maryland (January 2007). An initial medication history was completed by the nurse on hospice admission. The pharmacist did another medication history within 5 days of admission and compared the medication histories. All differences were reported as medication discrepancies. RESULTS: There were 504 medication discrepancies. Medication omissions occurred most commonly. All patients had at least 1 medication discrepancy (average 8.7 per patient). Overall, 190 drug interactions were identified; most were moderately severe. CONCLUSION: Terminal patients often use numerous medications increasing the risk of medication errors. Accurate medication histories reduce errors and potential for harm.